Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, announced today that Ophthalmology and Therapy published a new...
Business Wire·8d ago
More News
HC Wainwright Comments on Bausch + Lomb Q1 Earnings
Bausch + Lomb Corporation (NYSE:BLCO - Free Report) - Research analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Bausch + Lomb in a research report issued on Monday...
MarketBeat·8d ago
Bausch + Lomb (NYSE:BLCO) Reaches New 52-Week High - Here's What Happened
Bausch + Lomb (NYSE:BLCO) Hits New 1-Year High - Should You Buy...
MarketBeat·9d ago
Bausch + Lomb (NYSE:BLCO) Lowered to Hold Rating by Wall Street Zen
Wall Street Zen cut shares of Bausch + Lomb from a "buy" rating to a "hold" rating in a report on Saturday...
MarketBeat·11d ago
Bausch + Lomb (BLCO) Upgraded to Buy: Here's What You Should Know
Bausch + Lomb (BLCO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·13d ago
Wells Fargo & Company Forecasts Strong Price Appreciation for Bausch + Lomb (NYSE:BLCO) Stock
Wells Fargo & Company increased their price target on shares of Bausch + Lomb from $17.00 to $18.00 and gave the stock an "equal weight" rating in a research report on Thursday...
MarketBeat·13d ago
Bausch + Lomb (NYSE:BLCO) Shares Gap Down After Earnings Miss
Bausch + Lomb (NYSE:BLCO) Shares Gap Down Following Weak Earnings...
Bausch + Lomb (NYSE:BLCO - Get Free Report) posted its earnings results on Wednesday. The company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by...
MarketBeat·14d ago
Bausch + Lomb Q4 Earnings Call Highlights
Bausch + Lomb (NYSE:BLCO) executives highlighted what they described as a record fourth quarter and full-year 2025 performance, driven by broad-based revenue growth, accelerating profitability, and...
MarketBeat·14d ago
Bausch + Lomb (BLCO) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Bausch + Lomb (BLCO) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.